No doubt about it… the previous SAB was exceptional but this one is very very focused to brain cancer and they are names we are very familiar with who have been on this journey with us for years …
it’s all about commercialisation!
they are all joining as they know what we know Pax is the next valid more effective treatment for GBM sufferers extending lives and offering a more effective treatment to some 60+% of patients who previously would take Telozolomide for no real benefit at all.
even though this is wonderful news the general market won’t make the connections as the general market will school around winners once critical mass is obvious so this is when those with the information who know what it’s worth get set if they have the gumption.
DCA all the way.
Ann: Kazia launches new SAB, page-18
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)